Quantcast

Health Care Sector Update for 09/12/2017: AEMD,ALDX,SAGE


Shutterstock photo

Top Health Care Stocks

JNJ -0.50%

PFE +3.21%

ABT -0.40%

MRK +0.50%

AMGN +2.27%

Health care stocks have turned narrowly higher just before Tuesday's closing bell, with the NYSE Health Care Index rising nearly 0.2% today while shares of health care companies in the S&P 500 were up almost 0.1% as a group.

In company news, Aethlon Medical ( AEMD ) almost doubled in value early in Tuesday trading, rising almost 93% to an intra-day high of $2.90 a share, after the medical device company today said federal regulators have granted an expedited access pathway designation for its Aethlon Hemopurifier to treat life-threatening viruses.

The expedited access pathway program was created by the U.S. Food and Drug Administration to speed patient access to breakthrough technologies with the potential of addressing life-threatening conditions with no approved treatment alternatives.

In other sector news,

(+) ALDX, ADX-102 topical ocular drug candidate shows statistically significant improvement in patients with dry eye disease across multiple sign and symptom endpoints during Phase II patients.

(-) SAGE, Brexanolone drug candidate to treat a life-threatening seizure condition called super-refractory status epilepticus failed to meet its primary endpoint of statistical superiority compared with a placebo during Phase III testing.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: AEMD , ALDX , SAGE


More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities








Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com